SCHEMBL8768206

SCHEMBL8768206

C[C@]1(O)CC=C2[C@@H]3CC=C4CC5(CC[C@@H]4[C@H]3[C@@H](c3ccc(-c4ccsc4)cc3)C[C@@]21C)OCCO5

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8768957 0.87 ESR2 (0.31) —
SCHEMBL8768005 0.86 — —
SCHEMBL8767953 0.85 PARP1 (0.31) —
SCHEMBL8768846 0.80 — —
SCHEMBL8768906 0.78 — —
SCHEMBL8768195 0.76 PGR (0.36) —
SCHEMBL8768994 0.66 HSD17B1 (0.33) —
SCHEMBL8767932 0.64 — —
SCHEMBL8767954 0.64 CYP3A4 (0.33) —
SCHEMBL8768855 0.63 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0567469-B1 14beta-H-, 14- AND 15-EN-11beta-ARYL-4-ESTRENES SCHERING AG (DE) 1997-08-27 — — EP disclosed
US-5426102-A Antigestagenic, antiandrogenic, antiglucocorticoid, antimineralcorticoid properties SCHERING AKTIENGESELLSCHAFT (DE) 1995-06-20 — — US disclosed
Send feedback